BioMatrix Specialty Pharmacy has announced its Board of Directors unanimously selected Nick Karalis as the company's Chief Executive Officer. Karalis, who currently serves as BioMatrix Chief Operating Officer, assumed the role on July 1, 2019. He will also serve on the company's Board of Directors.
"We are pleased to select Nick as the CEO of BioMatrix," said Daniel Jinich, Chairman of the Board for BioMatrix. "Nick's clinical experience as a pharmacist combined with his business acumen and deep understanding of the specialty pharmacy industry will serve the organization well."
"I'm honored and grateful to the Board for the opportunity to lead this exceptional organization with dedicated professionals," said Karalis. "I've spent my entire career building and managing organizations uniting healthcare stakeholders to remove barriers to care and improve patient outcomes. We have an incredible team at BioMatrix and we are well positioned to become the premier national specialty pharmacy for patients with complex health conditions."
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from American Pharmaceutical Review – all delivered right to your inbox! Sign up now!
Karalis is a graduate of University of the Sciences (formerly PCPS) and has over 25 years of executive leadership experience as a pharmacist and pharmacy owner/operator. He was a founding principal and CEO of Elwyn Pharmacy Group, which became part of BioMatrix in 2017. He also was a co-founder and President at Community Specialty Pharmacy Network (CSPN). He is a member of Cardinal Health's National Advisory Board and on the Leadership Counsel for the American Red Cross. He is a founding Board member of Hellenic Hearts, a non-profit, and part of Leadership 100.